Non-small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Non-small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-11-04Clinical Trial Update: Study of Osimertinib and Stereotactic Ablative Radiation (SABR) in EGFR Mutant NSCLC [Phase 2]
Phase 2 study evaluating osimertinib combined with stereotactic ablative radiation (SABR) in EGFR-mutant non-small cell lung cancer.
-
CLINICAL_TRIALS research · 2025-11-04Clinical Trial Update: Evaluate BL-M17D1 in Patients w/HER2-Expressing/Mutant Advanced or Metastatic Solid Tumors [Phase 1]
Phase 1 clinical trial update for BL-M17D1 in patients with HER2-expressing or HER2-mutant advanced or metastatic solid tumors; the study is…
-
CLINICAL_TRIALS research · 2025-11-03Clinical Trial Update: Local Consolidative Therapy and Brigatinib in Treating Patients With Stage IV or Recurrent Non-small Cell Lung Cancer [Phase 1]
Phase 1 clinical trial evaluating local consolidative therapy plus brigatinib in patients with stage IV or recurrent ALK-rearranged non-smal…
-
CLINICAL_TRIALS research · 2025-10-30Clinical Trial Update: Developing a Shared Decision Making Tool for Patients With Surgically Removed Non-small Cell Lung Cancer
Clinical trial update from Mayo Clinic describes the completion of a study to develop a shared decision-making tool for patients who have ha…
-
CLINICAL_TRIALS research · 2025-10-30Clinical Trial Update: A Study of Neladalkib (NVL-655) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ALK Rearrangement or Activating ALK Mutation (ALKOVE-1) [Phase 1, Phase 2]
Nuvalent's neladalkib (NVL-655) is being studied in a Phase 1/2 trial (ALKOVE-1) for patients with advanced non-small cell lung cancer and o…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-10-29Clinical Trial Update: Study to Assess Adverse Events and Change in Disease Activity in Adult Participants With Advanced Solid Tumors Receiving Intravenous (IV) ABBV-400 as Monotherapy and in Combination With IV Bevacizumab [Phase 1]
A Phase 1 clinical trial update shows ABBV-400 alone or with bevacizumab being studied in adults with advanced solid tumors, including non-s…
-
CLINICAL_TRIALS research · 2025-10-29Clinical Trial Update: Biology of Young Lung Cancer Study: The YOUNG LUNG Study
The YOUNG LUNG Study is currently recruiting, focusing on the biology of lung cancer in younger patients.
-
CLINICAL_TRIALS research · 2025-10-28Clinical Trial Update: LUNAR-4: Effect of Tumor Treating Fields (TTFields) (150 kHz) Concurrent With Pembrolizumab for Treatment of Metastatic Non-small Cell Lung Cancer (NSCLC) [Phase 2]
Phase 2 trial evaluating Tumor Treating Fields (TTFields) at 150 kHz in combination with pembrolizumab for metastatic non-small cell lung ca…
-
CLINICAL_TRIALS research · 2025-10-28Clinical Trial Update: SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Clinical trial SYNERGY-AI is an AI-based precision oncology matching and registry study sponsored by Massive Bio, currently recruiting acros…
-
CLINICAL_TRIALS research · 2025-10-24Clinical Trial Update: NBTXR3 Activated by Radiotherapy for Patients With Advanced Cancers Treated With An Anti-PD-1 Therapy [Phase 1]
A Phase 1 trial evaluating NBTXR3 activated by radiotherapy in combination with anti-PD-1 therapy for patients with advanced cancers; the st…
-
CLINICAL_TRIALS research · 2025-10-24Clinical Trial Update: A Study Assessing KB707 for the Treatment of Advanced Solid Tumor Malignancies Affecting the Lungs [Phase 1, Phase 2]
Krystal Biotech's KB707 is being evaluated in a Phase 1/2 study for advanced solid tumors affecting the lungs, including non-small cell and …
-
CLINICAL_TRIALS research · 2025-10-22Clinical Trial Update: A Clinical Trial to Test if an Investigational Combination Therapy With BNT326 and BNT327 is Safe and Potentially Beneficial for People With Advanced Non-small Cell Lung Cancer (NSCLC) [Phase 1, Phase 2]
This document notes an ongoing Phase 1/2 clinical trial by BioNTech evaluating the safety and potential benefit of the investigational combi…
-
CLINICAL_TRIALS research · 2025-10-22Clinical Trial Update: Microwave Ablation or Wedge Resection for the Treatment of Lung, Sarcoma and Colorectal Lesions, ALLUME Study
The ALLUME Study is evaluating microwave ablation versus wedge resection for treatment of lung, sarcoma, and colorectal lesions, including v…
-
CLINICAL_TRIALS research · 2025-10-21Clinical Trial Update: First-in-human Study of DS-1062a for Advanced Solid Tumors (TROPION-PanTumor01) [Phase 1]
First-in-human Phase 1 study of DS-1062a for advanced solid tumors, including breast cancer subtypes and non-small cell lung cancer, is unde…
-
CLINICAL_TRIALS research · 2025-10-21Clinical Trial Update: Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer [Phase 1, Phase 2]
This is a Phase 1/Phase 2 clinical trial evaluating the immune response to a MUC1 peptide vaccine in patients with non-small cell lung cance…
-
CLINICAL_TRIALS research · 2025-10-20Clinical Trial Update: A Phase II Study of Neoadjuvant Sotorasib in Combination With Cisplatin or Carboplatin and Pemetrexed for Surgically Resectable Stage IIA-IIIB Non-Squamous Non-Small Cell Lung Cancer With a KRAS p.G12C Mutation [Phase 2]
A Phase II neoadjuvant trial is evaluating sotorasib in combination with cisplatin or carboplatin and pemetrexed for surgically resectable s…
-
CLINICAL_TRIALS research · 2025-10-20Clinical Trial Update: Gilteritinib for the Treatment of ALK NSCLC [Phase 1]
A Phase 1 trial evaluating gilteritinib for ALK-positive non-small cell lung cancer is currently recruiting.
-
CLINICAL_TRIALS research · 2025-10-20Clinical Trial Update: Quality of Life Intervention to Inform Patient Decision-Making in Early-Stage Lung Cancer [NA]
This clinical trial investigates a quality-of-life intervention to help patients with early-stage non-small cell lung cancer make informed t…
-
CLINICAL_TRIALS research · 2025-10-16Clinical Trial Update: Study of the Monoclonal Antibody IMT-009 in Patients With Advanced Solid Tumors or Lymphomas [Phase 1, Phase 2]
Clinical trial update describing a Phase 1/2 study of the monoclonal antibody IMT-009 in various advanced solid tumors and lymphomas, with t…
-
CLINICAL_TRIALS research · 2025-10-15Clinical Trial Update: Genetically Engineered Natural Killer (NK) Cells With or Without Atezolizumab for the Treatment of Non-small Cell Lung Cancer Previously Treated With PD-1 and/or PD-L1 Immune Checkpoint Inhibitors [Phase 1]
A Phase 1 clinical trial evaluating genetically engineered natural killer (NK) cells with or without atezolizumab for non-small cell lung ca…
-
CLINICAL_TRIALS research · 2025-10-15Clinical Trial Update: Predicting Responsiveness in Oncology Patients Based on Host Response Evaluation During Anti Cancer Treatments
An observational clinical trial from OncoHost Ltd. aims to predict responsiveness to anti-cancer treatments in patients with advanced cancer…
-
CLINICAL_TRIALS research · 2025-10-14Clinical Trial Update: eXalt3: Study Comparing X-396 (Ensartinib) to Crizotinib in ALK Positive Non-Small Cell Lung Cancer (NSCLC) Patients [Phase 3]
Update on the Phase 3 eXalt3 trial comparing Ensartinib (X-396) to Crizotinib in ALK-positive non-small cell lung cancer, with the study cur…
-
CLINICAL_TRIALS research · 2025-10-14Clinical Trial Update: Study of JANX008 in Subjects With Advanced or Metastatic Solid Tumor Malignancies [Phase 1]
A Phase 1 study of JANX008 in advanced or metastatic solid tumors is currently recruiting, evaluating multiple indications including Non-Sma…
-
CLINICAL_TRIALS research · 2025-10-10Clinical Trial Update: MOv19-BBz CAR T Cells in FRa+ Cancers [Phase 1]
Phase 1 trial evaluating MOv19-BBz CAR T cells targeting FRα in metastatic or recurrent non-small cell lung cancer is currently recruiting.
-
CLINICAL_TRIALS research · 2025-10-10Clinical Trial Update: Phase 1 Study of OP-3136 in Advanced or Metastatic Solid Tumors [Phase 1]
Phase 1 study evaluating OP-3136 in advanced or metastatic solid tumors, including ER-positive/HER2-negative breast cancer, non-small cell l…